New Potassium Binder Prevents Hyperkalemia in Patients with HF

Summary

An investigational potassium binder, RLY5016, prevented hyperkalemia in patients with heart failure, according to findings from the phase II PEARL-HF study [NCT00868439].

  • Cardiology Clinical Trials
  • Heart Failure
View Full Text